Gene Therapy Oversight Efforts Should Be Expanded To Other Areas - HHS IG

FDA and NIH should expand improvement efforts in gene therapy trial oversight to other types of clinical trials, the HHS Inspector General suggested in an update on recommendations for protecting human research subjects.